Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate COPD”

401 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 401 results

Large-scale testing (Phase 3)Looking for participantsNCT07363694
What this trial is testing

Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Who this might be right for
Moderate to Severe Chronic Obstructive Pulmonary Disease
Pfizer 1,156
Large-scale testing (Phase 3)Study completedNCT01202188
What this trial is testing

Assess the Efficacy, Safety and Tolerability of Once-daily (q.d.) QVA149 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Novartis Pharmaceuticals 2,144
Not applicableUnknownNCT02680769
What this trial is testing

Effect of Magnesium Supplementation in COPD

Who this might be right for
Pulmonary Disease, Chronic Obstructive
University of Padova 76
Testing effectiveness (Phase 2)Ended earlyNCT03345407
What this trial is testing

Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 943
Not applicableStudy completedNCT01355978
What this trial is testing

Non-invasive Ventilation System in Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic ObstructiveAirflow Obstruction, ChronicChronic Obstructive Airway Disease+1 more
Breathe Technologies, Inc. 22
Early research (Phase 1)WithdrawnNCT06340581
What this trial is testing

Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) With a Next-generation Propellant (NGP) With a Spacer, BGF MDI Hydrofluoroalkane (HFA) With a Spacer, as Well as BGF MDI NGP Without a Spacer

Who this might be right for
Healthy
AstraZeneca
Large-scale testing (Phase 3)Study completedNCT00669617
What this trial is testing

Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis 89
Not applicableStudy completedNCT00974220
What this trial is testing

Effect of Inhaled Fentanyl on Dyspnea and Exercise Tolerance in Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Queen's University 16
Large-scale testing (Phase 3)Study completedNCT02454959
What this trial is testing

Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD

Who this might be right for
COPD
Pearl Therapeutics, Inc. 80
Not applicableStudy completedNCT04168775
What this trial is testing

Peak Inspiratory Flow Rates in Patients With COPD

Who this might be right for
COPD
University of North Carolina, Chapel Hill 80
Post-approval studies (Phase 4)Study completedNCT05431218
What this trial is testing

Association of Cathelicidin and Vitamin D Levels With the Category and Course of COPD

Who this might be right for
Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease ModerateChronic Obstructive Pulmonary Disease Severe
Karaganda Medical University 120
Not applicableNot Yet RecruitingNCT07361653
What this trial is testing

The REVIVE Pivotal Study

Who this might be right for
COPD (Chronic Obstructive Pulmonary Disease)COPD ExacerbationsCOPD Patients+4 more
Ryme Medical, Inc. 300
Early research (Phase 1)Study completedNCT00568503
What this trial is testing

Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients.

Who this might be right for
COPD
Novartis 29
Post-approval studies (Phase 4)Study completedNCT01959516
What this trial is testing

Effect of Glycopyrronium on Morning Symptoms and Pulmonary Function in Patients With Moderate to Severe COPD

Who this might be right for
COPD
Novartis Pharmaceuticals 124
Post-approval studies (Phase 4)Study completedNCT03842904
What this trial is testing

A Study Comparing the Effects of Trimbow to Fostair in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Medicines Evaluation Unit Ltd 23
Large-scale testing (Phase 3)Study completedNCT01119937
What this trial is testing

Long Term Safety and Tolerability of NVA237 Versus Tiotropium in Japanese Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
Novartis Pharmaceuticals 211
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07759245
What this trial is testing

Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Eli Lilly and Company 606
Early research (Phase 1)Study completedNCT03906045
What this trial is testing

A Scintigraphy Study of PT010 in COPD Patients

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 18
Large-scale testing (Phase 3)Study completedNCT04542057
What this trial is testing

Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA 790
Large-scale testing (Phase 3)Study completedNCT04535986
What this trial is testing

Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA 763
Next Page